NO980566D0 - Allergen-XCD32 fusjonsproteiner - Google Patents

Allergen-XCD32 fusjonsproteiner

Info

Publication number
NO980566D0
NO980566D0 NO980566A NO980566A NO980566D0 NO 980566 D0 NO980566 D0 NO 980566D0 NO 980566 A NO980566 A NO 980566A NO 980566 A NO980566 A NO 980566A NO 980566 D0 NO980566 D0 NO 980566D0
Authority
NO
Norway
Prior art keywords
xcd32
allergen
fusion proteins
fusion
proteins
Prior art date
Application number
NO980566A
Other languages
English (en)
Other versions
NO980566L (no
Inventor
Geert C Mudde
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO980566L publication Critical patent/NO980566L/no
Publication of NO980566D0 publication Critical patent/NO980566D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO980566A 1995-08-16 1998-02-10 Allergen-XCD32 fusjonsproteiner NO980566D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (2)

Publication Number Publication Date
NO980566L NO980566L (no) 1998-02-10
NO980566D0 true NO980566D0 (no) 1998-02-10

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980566A NO980566D0 (no) 1995-08-16 1998-02-10 Allergen-XCD32 fusjonsproteiner

Country Status (16)

Country Link
EP (1) EP0846178A1 (no)
JP (1) JPH11513025A (no)
KR (1) KR19990036440A (no)
CN (1) CN1193353A (no)
AU (1) AU6873596A (no)
BR (1) BR9610239A (no)
CA (1) CA2227795A1 (no)
CZ (1) CZ43798A3 (no)
GB (1) GB9516760D0 (no)
HU (1) HUP9802349A3 (no)
IL (1) IL122898A0 (no)
NO (1) NO980566D0 (no)
PL (1) PL324897A1 (no)
SK (1) SK19398A3 (no)
TR (1) TR199800214T1 (no)
WO (1) WO1997007218A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
US6682928B2 (en) 1997-12-02 2004-01-27 Medarex, Inc. Cells expressing anti-Fc receptor binding components
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (bg) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Средство за селективно подтискане на патологични днк - специфични в клетки
BG65954B1 (bg) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Средство за селективно подтискане активността на патологични автореактивни в-клетки
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
HUE052481T2 (hu) 2012-06-15 2021-04-28 Immunomic Therapeutics Inc Nukleinsavak, allergiák kezelésére
CN109806387B (zh) 2012-07-13 2022-03-04 S-目标疗法有限公司 免疫调节疫苗
DK2914285T3 (en) * 2012-11-01 2017-02-27 Veterinærinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
HUE037252T2 (hu) 2013-05-21 2018-08-28 Tyg Oncology Ltd Gasztrin peptid immunogenikus kompozíció
CN113186167B (zh) * 2021-04-28 2021-11-30 中国食品药品检定研究院 用于测定抗cd20单克隆抗体药物adcp生物学活性的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
EP0759782A1 (en) * 1994-05-26 1997-03-05 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
PL324897A1 (en) 1998-06-22
NO980566L (no) 1998-02-10
AU6873596A (en) 1997-03-12
KR19990036440A (ko) 1999-05-25
HUP9802349A2 (hu) 1999-01-28
WO1997007218A1 (en) 1997-02-27
CZ43798A3 (cs) 1998-06-17
MX9801253A (es) 1998-05-31
JPH11513025A (ja) 1999-11-09
CN1193353A (zh) 1998-09-16
GB9516760D0 (en) 1995-10-18
BR9610239A (pt) 1999-06-15
CA2227795A1 (en) 1997-02-27
IL122898A0 (en) 1998-08-16
EP0846178A1 (en) 1998-06-10
TR199800214T1 (xx) 1998-06-22
HUP9802349A3 (en) 1999-04-28
SK19398A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
DK0807198T3 (da) Sammenføjningssystem
DE69625368T2 (de) Schweisshemmende deodorierende präparaten
DE69839603D1 (de) Zierenden proteins
DE69621211D1 (de) Gelenkanordnung
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
DK0825860T3 (da) Præpart
NO976058L (no) Rekombinant mistellectin
DK132892D0 (da) Proteiner
BR9508433A (pt) Peptídeos
BR9609671A (pt) Amino uracilas substituídas
FI972763A (fi) Mutanttiproteiineja
DE69607261T2 (de) Anschlussbrücke
DE29503122U1 (de) Sonotrode
TR199701666A3 (tr) Sismanliga karsi proteinler
BR9606756A (pt) Peptídeo
FR2733287B1 (fr) Joint homocinetique
NO981052D0 (no) Peptidderivater
DE69625037D1 (de) Schrottschmelzverfahren
NO981051D0 (no) Peptidderivater
DK0862197T3 (da) Sikringsstik
DE29504095U1 (de) Kippendose
DE59500958D1 (de) Gliederbrücke
BR9609863A (pt) Fecho
DE29518254U1 (de) Laufrad-Welle-Verbindung
KR970018128U (ko) 토건용 축조부재